Posted on 10 月 8, 202410/8/24
EVERSANA Expands Safety Case Management Capabilities with Oracle
Posted on 10 月 8, 202410/8/24
EVERSANA President Greg Skalicky Named to Prestigious 2024 PharmaVoice 100 List
Posted on 10 月 7, 202410/7/24
EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office
Posted on 6 月 17, 20246/17/24
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Posted on 3 月 25, 20243/25/24
EVERSANA and MyHealthTeam Launch Groundbreaking Direct-to-Patient Solution to Accelerate Time to Diagnosis and Treatment
Posted on 3 月 21, 20243/21/24
EVERSANA Named AI Excellence Award Winner for Third Consecutive Year, Recognized in Company Category for 2024
Posted on 3 月 12, 20243/12/24